0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Corticosteroids Therapy Market by Route Of Administration, Indication, Drug Type, Dosage Form, Patient Age Group - Global Forecast to 2030- Product Image
Corticosteroids Therapy Market by Route Of Administration, Indication, Drug Type, Dosage Form, Patient Age Group - Global Forecast to 2030- Product Image
Sale

Corticosteroids Therapy Market by Route Of Administration, Indication, Drug Type, Dosage Form, Patient Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888287
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Corticosteroids Therapy Market is experiencing robust growth, expanding from USD 5.26 billion in 2024 to USD 5.69 billion in 2025, with projections to reach USD 8.25 billion by 2030.

This growth is largely driven by the escalating prevalence of inflammatory and autoimmune disorders, positioning corticosteroid therapies as integral to contemporary treatment strategies. The shift from broad systemic agents to refined, precision-guided formulations underscores corticosteroids' crucial role in managing chronic and acute conditions across various medical fields.

Innovations Shaping Corticosteroid Therapy

Corticosteroid treatments have seen significant innovations in both formulation and delivery methods. Enhanced inhalation systems, such as dry powder inhalers and smart inhalers, improve drug targeting while reducing systemic exposure, fostering better outcomes for respiratory patients. Additionally, advancements in topical and injectable formulations—utilizing microemulsion and liposomal carriers—introduce sustained release options and deeper tissue penetration, addressing chronic inflammatory disorders effectively. Such innovations offer strategic advantages, fostering competitive differentiation in a crowded marketplace.

The integration of digital health platforms further bolsters treatment regimens, providing personalized therapy reminders, symptom tracking, and telehealth support. These technologies facilitate patient engagement, generating real-time data that enhances clinical decisions while tailoring treatments to individual needs. Such advancements offer a competitive edge, ensuring companies stay at the forefront of patient-centered healthcare innovations.

Impact of the 2025 Tariff Changes

The 2025 United States tariff adjustments present a pivotal moment for the global corticosteroid supply chain, affecting cost structures for both raw materials and finished products. To counter these challenges, many manufacturers are localizing production and expanding domestic capabilities, partnering with regional contract development organizations to maintain competitive pricing. This shift encourages efficiencies that provide mitigation against external cost pressures and strengthen supply chain resilience.

Smaller players face particular challenges due to heightened cost pressures, leading to increased consolidation activities within the industry. This has driven mergers and acquisitions, aimed at achieving economies of scale and bolstering supply chain stability, thereby ensuring sustained competitive positioning.

Key Takeaways from This Report

  • Innovative delivery technologies are enhancing corticosteroids' therapeutic impact while improving patient adherence and outcomes.
  • Tariffs are reshaping industry dynamics, prompting sourcing strategy revisions and manufacturing localization efforts.
  • Targeted market approaches and strategic collaborations are essential for capitalizing on emerging demand trends.

In-Depth Market Segmentation Analysis

Inhalation modalities lead the market, particularly dry powder inhalers, metered dose inhalers, and nebulizers, largely for their impact in managing chronic respiratory conditions. Injectable formulations, including intramuscular, intravenous, and subcutaneous methods, stand out in acute care, while oral and topical forms fulfill systemic and localized treatments, respectively. Understanding these segments helps businesses identify opportunities and align product strategies effectively.

Within therapeutic indications, allergic rhinitis, asthma, dermatological disorders, inflammatory bowel disease, and rheumatoid arthritis emerge as critical areas, driven by increased environmental triggers and diagnostic capabilities. Leaders in drug innovation include budesonide and dexamethasone, with availability across both branded and generic markets guiding access and pricing strategies.

Regional Market Performance Highlights

In the Americas, robust reimbursement frameworks and clinical infrastructure underpin market growth. The United States drives innovation, while Latin America shows consistent generic uptake. In Europe, Middle East & Africa, Western Europe leads with regulatory-driven adoption, while emerging markets adapt to variable reimbursement. Asia-Pacific's growth, spurred by increasing healthcare investment and industrialization, positions the region as a key market player.

Competitive Landscape Insight

Dominated by multinational corporations, the market sees strategic collaborations enhancing product portfolios through advanced delivery systems. Generic manufacturers, scaling to meet cost-effective demand, leverage swift market entries facilitated by regulatory pathways. Industry alliances and the acquisition of innovative entities enhance competitive advantages, ensuring resilience in a dynamic marketplace.

Strategic Recommendations for Industry Leaders

To navigate emerging market dynamics, leaders should focus on next-gen delivery tech, enhance supply chain resilience, and explore strategic partnerships. Embracing digital solutions for real-world evidence generation will bolster negotiation capabilities, while prioritizing research within pediatric and geriatric segments will unlock new market opportunities. Such strategies leverage technological advances and market insights, facilitating sustainable growth against a backdrop of global challenges.

Comprehensive Research Methodology

The report employs a mixed-methods research approach for comprehensive insights into the market. Combining primary in-depth interviews with secondary data analysis from reliable sources ensures well-rounded findings. Quantitative modeling validates trends across key segments, while geographic analyses establish contextual relevance, ensuring informed strategic planning for stakeholders.

This nuanced exploration of the corticosteroid market landscape equips industry leaders with the intelligence needed to craft informed strategies, ensuring robust market positioning and long-term success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Corticosteroids Therapy Market, by Route Of Administration
8.1. Introduction
8.2. Inhalation
8.2.1. Dry Powder Inhaler
8.2.2. Metered Dose Inhaler
8.2.3. Nebulizer
8.3. Injectable
8.3.1. Intramuscular
8.3.2. Intravenous
8.3.3. Subcutaneous
8.4. Oral
8.4.1. Suspension
8.4.2. Tablet
8.5. Topical
8.5.1. Cream
8.5.2. Lotion
8.5.3. Ointment
9. Corticosteroids Therapy Market, by Indication
9.1. Introduction
9.2. Allergic Rhinitis
9.3. Asthma
9.4. Dermatological Disorders
9.5. Inflammatory Bowel Disease
9.6. Rheumatoid Arthritis
10. Corticosteroids Therapy Market, by Drug Type
10.1. Introduction
10.2. Budesonide
10.3. Dexamethasone
10.4. Hydrocortisone
10.5. Methylprednisolone
10.6. Prednisone
11. Corticosteroids Therapy Market, by Dosage Form
11.1. Introduction
11.2. Cream
11.3. Injection
11.4. Suspension
11.5. Tablet
12. Corticosteroids Therapy Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Americas Corticosteroids Therapy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Corticosteroids Therapy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Corticosteroids Therapy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. AstraZeneca plc
16.3.3. Novartis AG
16.3.4. Sanofi S.A.
16.3.5. Merck & Co., Inc.
16.3.6. Pfizer Inc.
16.3.7. Teva Pharmaceutical Industries Ltd
16.3.8. Sun Pharmaceutical Industries Ltd
16.3.9. Mylan N.V.
16.3.10. Sandoz International GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CORTICOSTEROIDS THERAPY MARKET MULTI-CURRENCY
FIGURE 2. CORTICOSTEROIDS THERAPY MARKET MULTI-LANGUAGE
FIGURE 3. CORTICOSTEROIDS THERAPY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CORTICOSTEROIDS THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CORTICOSTEROIDS THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CORTICOSTEROIDS THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY OINTMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY BUDESONIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PREDNISONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 69. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 70. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 71. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 72. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 75. CANADA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 122. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 127. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 130. GERMANY CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 131. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 133. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 135. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 136. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 139. FRANCE CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 149. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 151. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 152. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 153. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 154. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 157. ITALY CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 158. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 160. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 161. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 162. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 163. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 166. SPAIN CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 194. DENMARK CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 195. DENMARK CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 196. DENMARK CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 197. DENMARK CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 198. DENMARK CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 199. DENMARK CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 200. DENMARK CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 201. DENMARK CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 202. DENMARK CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. QATAR CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. QATAR CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 214. QATAR CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 215. QATAR CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 216. QATAR CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 217. QATAR CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 218. QATAR CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 219. QATAR CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 220. QATAR CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. FINLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 222. FINLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 223. FINLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 224. FINLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 225. FINLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 226. FINLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 227. FINLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 228. FINLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 229. FINLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 248. EGYPT CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. EGYPT CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 250. EGYPT CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 251. EGYPT CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 252. EGYPT CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 253. EGYPT CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 254. EGYPT CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 256. EGYPT CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 257. TURKEY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 258. TURKEY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 259. TURKEY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 260. TURKEY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 261. TURKEY CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 262. TURKEY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 263. TURKEY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 265. TURKEY CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 275. NORWAY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. NORWAY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 277. NORWAY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 279. NORWAY CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 280. NORWAY CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 281. NORWAY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 282. NORWAY CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 283. NORWAY CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 284. POLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 285. POLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 286. POLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 287. POLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 288. POLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 289. POLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 290. POLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 291. POLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 292. POLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 311. ASIA-PACIFIC CORTICOSTEROIDS THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 312. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 313. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 314. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 315. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 316. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 317. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 318. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 319. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 320. CHINA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 321. INDIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 322. INDIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 323. INDIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 324. INDIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 325. INDIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 326. INDIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 327. INDIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 328. INDIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 329. INDIA CORTICOSTEROIDS THERAPY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 330. JAPAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 331. JAPAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INHALATION, 2018-2030 (USD MILLION)
TABLE 332. JAPAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 333. JAPAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 334. JAPAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 335. JAPAN CORTICOSTEROIDS THERAPY MARKET SIZE, BY IND

Companies Mentioned

The companies profiled in this Corticosteroids Therapy market report include:
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Novartis AG
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Mylan N.V.
  • Sandoz International GmbH

Methodology

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.25 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Corticosteroids Inhalation Formulation Market by End User, Indication, Distribution Channel, Dosage Form, Molecule - Global Forecast to 2030 - Product Image

Corticosteroids Inhalation Formulation Market by End User, Indication, Distribution Channel, Dosage Form, Molecule - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Adrenal Corticosteroid Inhibitors Market by Route Of Administration, Mechanism Of Action, Application, Distribution Channel, Molecule Type, End User - Global Forecast to 2030 - Product Image

Adrenal Corticosteroid Inhibitors Market by Route Of Administration, Mechanism Of Action, Application, Distribution Channel, Molecule Type, End User - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Corticosteroids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Corticosteroids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
EUR$4,500USDGBP
Corticosteroids Therapy - Global Strategic Business Report - Product Image

Corticosteroids Therapy - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From
EUR$5,850USDGBP
Nasal Corticosteroids - Global Strategic Business Report - Product Image

Nasal Corticosteroids - Global Strategic Business Report

  • Report
  • 469 Pages
  • Global
From
EUR$5,850USDGBP

About the Corticosteroid Market

The Corticosteroid market is a segment of the Healthcare Services industry that focuses on the production and distribution of corticosteroid drugs. Corticosteroids are a class of drugs used to treat a variety of conditions, including allergies, asthma, and autoimmune diseases. They are also used to reduce inflammation and swelling. Corticosteroids are available in both oral and injectable forms, and are often prescribed in combination with other medications. The Corticosteroid market is highly competitive, with a number of large pharmaceutical companies producing and distributing these drugs. Companies in the market are focused on developing new formulations and delivery systems to improve patient outcomes. They are also investing in research and development to create new treatments for a variety of conditions. Some of the major companies in the Corticosteroid market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. These companies are involved in the production, distribution, and marketing of corticosteroid drugs. They are also involved in research and development to create new treatments and formulations. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more